IL110413A0 - Agonists and antagonists of human interleukin-10 - Google Patents

Agonists and antagonists of human interleukin-10

Info

Publication number
IL110413A0
IL110413A0 IL11041394A IL11041394A IL110413A0 IL 110413 A0 IL110413 A0 IL 110413A0 IL 11041394 A IL11041394 A IL 11041394A IL 11041394 A IL11041394 A IL 11041394A IL 110413 A0 IL110413 A0 IL 110413A0
Authority
IL
Israel
Prior art keywords
agonists
antagonists
human interleukin
interleukin
human
Prior art date
Application number
IL11041394A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL110413A0 publication Critical patent/IL110413A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11041394A 1993-07-26 1994-07-22 Agonists and antagonists of human interleukin-10 IL110413A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894393A 1993-07-26 1993-07-26

Publications (1)

Publication Number Publication Date
IL110413A0 true IL110413A0 (en) 1994-10-21

Family

ID=22271670

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11041394A IL110413A0 (en) 1993-07-26 1994-07-22 Agonists and antagonists of human interleukin-10

Country Status (17)

Country Link
EP (1) EP0711346A1 (hu)
JP (1) JPH08507930A (hu)
KR (1) KR960704041A (hu)
CN (1) CN1127529A (hu)
AU (1) AU681178B2 (hu)
CA (1) CA2168110A1 (hu)
CZ (1) CZ23396A3 (hu)
FI (1) FI960353A0 (hu)
HU (1) HUT73463A (hu)
IL (1) IL110413A0 (hu)
NO (1) NO960309D0 (hu)
NZ (1) NZ269663A (hu)
PL (1) PL312718A1 (hu)
SG (1) SG43798A1 (hu)
SK (2) SK8396A3 (hu)
WO (1) WO1995003411A1 (hu)
ZA (1) ZA945434B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9508243A (pt) 1994-07-05 1997-10-21 Steeno Res Group As Imunomoduladores
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
WO1997026278A1 (en) 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
DE19851675A1 (de) * 1998-11-10 2000-05-11 Bayer Ag Menschliche Interleukin-10 Mutantenproteine
CN1441677A (zh) 2000-03-31 2003-09-10 Idec药物公司 抗细胞因子抗体或拮抗剂与抗－cd20在b细胞淋巴瘤治疗中的联合应用
WO2002026265A2 (en) 2000-09-29 2002-04-04 Schering Corporation Pegylated interleukin-10
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
EP2816118B1 (en) 2005-05-31 2018-10-17 The Regents of the University of Colorado, a body corporate Methods for delivering genes
AU2007314501B2 (en) 2006-09-28 2013-05-23 Merck Sharp & Dohme Corp. Use of pegylated IL-10 to treat cancer
US9493564B2 (en) 2008-10-02 2016-11-15 Aptevo Research And Development Llc CD86 antagonist multi-target binding proteins
RU2549702C2 (ru) 2008-12-17 2015-04-27 Мерк Шарп И Доум Корп., Получение и применение моно- и ди-пэг il-10
ES2683844T3 (es) 2011-11-08 2018-09-28 Umc Utrecht Holding B.V. Proteína de fusión que comprende una interleucina 4 e interleucina 10
CN106913865A (zh) 2013-04-18 2017-07-04 阿尔莫生物科技股份有限公司 使用白细胞介素‑10治疗疾病和病症的方法
JP2016526014A (ja) * 2013-04-24 2016-09-01 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１０組成物及びその使用
EP3010527B1 (en) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Method for assessing protein identity and stability
CN105658232A (zh) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
RU2016122957A (ru) 2013-11-11 2017-12-19 Армо Байосайенсиз, Инк. Способы применения интерлейкина-10 для лечения заболеваний и расстройств
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
AU2015333827A1 (en) 2014-10-14 2017-04-20 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
KR20170084033A (ko) 2014-10-22 2017-07-19 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위해 인터루킨-10을 사용하는 방법
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016191587A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
WO2017035232A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
EP3955956A1 (en) 2019-04-19 2022-02-23 Synerkine Pharma B.V. Therapeutic crosslinking of cytokine receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113229A (ja) * 1987-10-27 1989-05-01 Inahata Kenkyusho:Kk 多孔質ハニカム構成材
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
ES2138976T3 (es) * 1991-08-06 2000-02-01 Schering Corp Uso de analogos o antagonistas de interleucina-10 para tratar la toxicidad inducida por endotoxinas o superantigenos.

Also Published As

Publication number Publication date
SK150596A3 (en) 1997-04-09
SG43798A1 (en) 1997-11-14
AU681178B2 (en) 1997-08-21
WO1995003411A1 (en) 1995-02-02
CN1127529A (zh) 1996-07-24
JPH08507930A (ja) 1996-08-27
NO960309L (no) 1996-01-25
NZ269663A (en) 1997-09-22
SK8396A3 (en) 1997-03-05
FI960353A (fi) 1996-01-26
CZ23396A3 (en) 1996-05-15
KR960704041A (ko) 1996-08-31
AU7399694A (en) 1995-02-20
NO960309D0 (no) 1996-01-25
CA2168110A1 (en) 1995-02-02
FI960353A0 (fi) 1996-01-26
HU9503983D0 (en) 1996-03-28
PL312718A1 (en) 1996-05-13
ZA945434B (en) 1995-01-23
EP0711346A1 (en) 1996-05-15
HUT73463A (en) 1996-08-28

Similar Documents

Publication Publication Date Title
IL110413A0 (en) Agonists and antagonists of human interleukin-10
EP0880356A4 (en) ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF
GB9300213D0 (en) Wrist and hand support
IL106732A0 (en) Human interleukin-13
ZA936097B (en) Human interleukin-13
AR243240A1 (es) Procedimiento para preparar una proteina con actividad de factor estimulador de colonia y acido nucleico que comprende una secuencia nucleotidica capaz de modificarla.
ZA9710979B (en) Novel heterocyclically substituted benzamides and their use
EP0586687A4 (en) Trans-sialidase and methods of use and making thereof
EP0729300A4 (en) FAS PROTEIN AND METHOD FOR ITS USE
HU9600241D0 (en) Mutable composition and methods of use thereof
HU9402361D0 (en) New makrolides and use of them
GB9219425D0 (en) Therapeutic agent and its use
EP0786001A4 (en) CHEMOKIN-LIKE PROTEINS AND THEIR USE
AU4596896A (en) Substituted benzamides and radioligand analogs and methods of use
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
AU3681795A (en) Polypeptide agonists and antagonists of human interleukin-8
GB2294637B (en) Therapeutic compositions and methods of use
HUP9800146A3 (en) Thalidomide-derivatives and use of them
GB8923571D0 (en) Connecting means and method of use thereof
PL307138A1 (en) Amyline antagonists and agonists
EP0540575A4 (en) Human meg-csf protein and methods
KR910007551B1 (en) Polyethylene terephchalate and its use
GB9501907D0 (en) Allatostatins and their use
GB9314512D0 (en) Composition and use
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use